Xi Lays Out Broad China Policy Directions As National Congress Opens
COVID Zero, Insurance, Quality Of Life Key Pillars
Executive Summary
During his two-hour speech to the Chinese Communist Party's National Congress, general secretary and country president Xi Jinping said China's "COVID Zero" policy was here to stay and vowed to place equal importance on physical and mental health under a Healthy China initiative, in a series of declarations on general policy directions for the next five years.
You may also be interested in...
Lockdown To Reopening: China Rebound Uncertain As Biotech Remains In Survival Mode
The short-notice reopening of the country made 2022 a tough year for the health sector in China, where divestments, cash crunches and commercial challenges abounded. Throughout the year, despite clinical trial activity continuing to blossom, multiple Chinese innovative drug developers faced setbacks in the US from regulatory rejections of oncology products. Meanwhile, others quietly scaled back their operations in China, hit by the negative impact of deep price cuts.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues.
Medtechs Must Reflect On China Localization Policies As VBP Expands
China continues to roll out volume-based procurement for medical devices and pharma products and companies should plan their strategies accordingly, advises EY Parthenon’s Hua Su.